BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 11882685)

  • 21. Structural basis for membrane attack complex inhibition by CD59.
    Couves EC; Gardner S; Voisin TB; Bickel JK; Stansfeld PJ; Tate EW; Bubeck D
    Nat Commun; 2023 Feb; 14(1):890. PubMed ID: 36797260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.
    Navenot JM; Villanova M; Lucas-Héron B; Malandrini A; Blanchard D; Louboutin JP
    Muscle Nerve; 1997 Jan; 20(1):92-6. PubMed ID: 8995588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between channel size and the number of C9 molecules in the C5b-9 complex.
    Ramm LE; Whitlow MB; Mayer MM
    J Immunol; 1985 Apr; 134(4):2594-9. PubMed ID: 2579147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane permeability to macromolecules mediated by the membrane attack complex.
    Malinski JA; Nelsestuen GL
    Biochemistry; 1989 Jan; 28(1):61-70. PubMed ID: 2706268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells.
    Sawant-Mane S; Piddlesden SJ; Morgan BP; Holers VM; Koski CL
    J Neuroimmunol; 1996 Sep; 69(1-2):63-71. PubMed ID: 8823377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homologous restriction factor: effect on complement C8 and C9 uptake and lysis.
    Zalman LS; Müller-Eberhard H
    Mol Immunol; 1994 Mar; 31(4):301-5. PubMed ID: 8139583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identity of the segment of human complement C8 recognized by complement regulatory protein CD59.
    Lockert DH; Kaufman KM; Chang CP; Hüsler T; Sodetz JM; Sims PJ
    J Biol Chem; 1995 Aug; 270(34):19723-8. PubMed ID: 7544344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chimeras of human complement C9 reveal the site recognized by complement regulatory protein CD59.
    Hüsler T; Lockert DH; Kaufman KM; Sodetz JM; Sims PJ
    J Biol Chem; 1995 Feb; 270(8):3483-6. PubMed ID: 7533152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identity of a peptide domain of human C9 that is bound by the cell-surface complement inhibitor, CD59.
    Chang CP; Hüsler T; Zhao J; Wiedmer T; Sims PJ
    J Biol Chem; 1994 Oct; 269(42):26424-30. PubMed ID: 7523406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
    Ninomiya H; Sims PJ
    J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement membrane attack complex and protectin (CD59) in liver allografts during acute rejection.
    Lautenschlager I; Höckerstedt K; Meri S
    J Hepatol; 1999 Sep; 31(3):537-41. PubMed ID: 10488715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Affinity of the C9 molecule for the C5b-8 complex compared with that for the complex containing C9 molecules.
    MacKay SL; Dankert JR
    Infect Immun; 1994 Jul; 62(7):2800-5. PubMed ID: 8005670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
    Kontermann R; Deppisch R; Rauterberg EW
    Eur J Immunol; 1990 Mar; 20(3):623-8. PubMed ID: 1690659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.
    Li Y; Parks GD
    Viruses; 2018 Apr; 10(5):. PubMed ID: 29693588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amplified gene expression in CD59-transfected Chinese hamster ovary cells confers protection against the membrane attack complex of human complement.
    Zhao J; Rollins SA; Maher SE; Bothwell AL; Sims PJ
    J Biol Chem; 1991 Jul; 266(20):13418-22. PubMed ID: 1712784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neoepitope of the complement C5b-9 Membrane Attack Complex is formed by proximity of adjacent ancillary regions of C9.
    Bayly-Jones C; Ho BHT; Lau C; Leung EWW; D'Andrea L; Lupton CJ; Ekkel SM; Venugopal H; Whisstock JC; Mollnes TE; Spicer BA; Dunstone MA
    Commun Biol; 2023 Jan; 6(1):42. PubMed ID: 36639734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The killer molecule of complement.
    Müller-Eberhard HJ
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):47s-52s. PubMed ID: 3891882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
    Rosenfeld SI; Packman CH; Leddy JP
    J Clin Invest; 1983 Apr; 71(4):795-808. PubMed ID: 6403580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.